Over 250 Muscovites vaccinated for coronavirus in 5 days of trials, 25% feverish
MOSCOW. Sept 14 (Interfax) - More than 250 Muscovites have been inoculated against coronavirus in the first five days of the Phase 3 clinical trials of the Sputnik V coronavirus vaccine, the city operative headquarters told Interfax on Monday.
"The absolute majority is fine: 75% of participants in the trials have neither symptoms, nor any discomfort," a representative of the headquarters said. A quarter of those vaccinated developed mild symptoms: they were mildly feverish, the representative said.
The vaccine is being tested by seven centers; their number will grow to 20 this week, the Moscow city administration said.
Check-ups of the people who have volunteered to participate in the coronavirus vaccine trials began in Moscow on Monday. Doctors are examining and testing the volunteers in order to find subjects with no counter-indications to being vaccinated.
The first batch of the Sputnik V coronavirus vaccine developed by the Gamaleya Institute has been put into civil circulation. It will be used to vaccinate people from at-risk groups, primarily medical personnel. People from at-risk groups will be vaccinated simultaneously with the Phase 3 clinical trials (formally, post-registration trials) that have begun in Moscow.